UnitedHealth Group (NYSE: UNH) shares have drawn significant attention from investors following a period of notable price volatility. The healthcare giant, one of the largest publicly traded companies in the sector, has seen its valuation shift considerably over the past year, with the stock trading near the lower end of its 52-week range. Understanding the current UnitedHealth share price requires examining multiple data points, including intraday movements, trading volumes, and the broader factors influencing market sentiment around the company.
This article provides a comprehensive overview of UnitedHealth Group stock performance, drawing on available market data and analyst perspectives. For investors tracking UNH on Yahoo Finance or considering a position, the information below offers a snapshot of where the stock stands and what may be driving recent price action.
What is the Current UnitedHealth Share Price?
Latest market data shows UnitedHealth Group shares trading in the range of $304.33 to $310.14 depending on the platform and timing of the quote. One major trading platform recorded the stock at $304.33, representing a decline of $2.58 or approximately 0.84% from the previous close of $306.91. The intraday range extended from $304.20 at the low to $310.37 at the high. Trading volume reached approximately 5 to 8.18 million shares, with the average volume around 8.6 million shares.
Alternative real-time data from another platform listed the price at $310.14, up 1.8% from the day’s low of $304.54 but still down 1.5% from the intraday high of $314.80. The stock opened at $313.89. The bid and ask prices stood at $304.80 and $304.88 respectively, with 907.68 million shares outstanding. These variations reflect the natural lag and update cycles across different market data providers.
Search results show some data inconsistencies across sources, including price fluctuations and P/E ratio variance. This is typical during active trading sessions as different platforms update at varying frequencies. For intraday accuracy, prioritize recent quotes from major retail brokerage platforms and established financial data providers.
Overview Grid: UnitedHealth at a Glance
Key Market Insights
- UnitedHealth shares are trading near the lower end of their 52-week range, having fallen significantly from the $622.83 high recorded in the past year.
- The stock has declined approximately 50.55% over the past 12 months, reflecting broader concerns about healthcare policy and Medicare Advantage profitability.
- Year-to-date decline stands at 47.31%, with the stock hitting a 22-week low of $294.76 in January 2026.
- Options traders appear moderately bearish, with light volume of 128,000 contracts reported and shares trading around $308.56 after a 1.67% drop.
- The company recently announced plans to drop approximately 1 million Medicare Advantage members, a decision that has influenced investor sentiment.
- Recent analyst price targets suggest continued pressure, with forecasts pointing toward the $229 to $251 range over the coming quarters.
- Despite recent weakness, the company maintains a market capitalization exceeding $276 billion, making it one of the largest healthcare companies globally.
UnitedHealth Group Key Metrics
| Metric | Value |
|---|---|
| Market Capitalization | $276.23 – $279.98 Billion |
| P/E Ratio | 16.13 – 23.00 |
| Dividend Yield | 2.79% – 2.8% |
| 52-Week High | $622.83 |
| 52-Week Low | $234.60 |
| Shares Outstanding | 907.68 Million |
| Average Volume | 8.6 Million Shares |
| Previous Close | $306.91 |
How Has UNH Stock Performed Today and Recently?
The current trading session has seen UnitedHealth shares under pressure, with the price dipping below the $310 level across most major platforms. The stock has demonstrated considerable volatility throughout the day, oscillating between $304.20 and $310.37. This movement comes amid elevated trading activity, with volume exceeding the daily average in early sessions.
Recent Price Performance Trends
UnitedHealth has experienced a challenging period over the past several weeks and months. Over the last four weeks, the stock has declined by approximately 12.18%. The 12-month picture shows an even steeper descent, with shares losing more than half their value from levels above $600 to the current range around $304. The stock touched a 22-week low of $294.76 in January 2026, representing significant pressure from all-time highs.
Despite these declines, some technical indicators suggest the stock may be finding support at current levels. The 5-week low of approximately $271.75 has not been revisited, and the stock has recovered somewhat from recent lows. However, the overall trend remains downward, with the price still near the lower end of the established 52-week range spanning from $234.60 to $622.83.
The 52-week range provides context for where the current price sits relative to the stock’s annual performance. With UnitedHealth trading near $304, the stock has retreated approximately 51% from its 52-week high of $622.83, illustrating the magnitude of the recent pullback experienced by the healthcare giant.
Intraday Trading Activity
Trading activity on this session shows the stock underperforming broader market benchmarks. The opening price of $313.89 quickly gave way to selling pressure, driving the price below the $305 level before a modest recovery attempt. Bid and ask spreads remain relatively tight at $304.80 and $304.88, suggesting reasonable liquidity despite the day’s decline.
What Factors Are Driving UnitedHealth Stock Price Changes?
Several interconnected factors have contributed to the recent performance of UnitedHealth shares. Understanding these drivers requires examining both company-specific developments and broader market conditions affecting the healthcare sector.
Medicare Advantage Membership Reductions
One of the most significant factors influencing recent price action has been the company’s announcement regarding its Medicare Advantage business. UnitedHealth plans to drop approximately 1 million Medicare Advantage members, a decision that has raised questions about the profitability trajectory of this important business segment. This announcement came during comments at the UBS Global Healthcare Conference, with Chief Financial Officer Wayne DeVey addressing the strategic shift.
Medicare Advantage has been a crucial growth driver for major healthcare insurers, but rising medical costs and regulatory pressures have begun to weigh on margins. UnitedHealth’s decision to reduce membership in this program signals a strategic recalibration in response to these challenging conditions.
Earnings Performance and Guidance
Recent quarterly results have shown mixed signals for the company. The fourth quarter of fiscal year 2025 saw earnings per share of $2.11 to $2.12 against consensus estimates of $2.09, according to some reports. However, other data points indicate significant variance, with some sources listing consensus estimates much higher at $6.81 per share. These discrepancies highlight the complexity of tracking company performance across multiple data providers.
The third quarter of 2025 showed EPS of $2.92, matching consensus estimates of $2.90. The second quarter came in at $4.08 against estimates of $6.22, representing a notable miss. For the first quarter of 2026, analysts are forecasting EPS of $6.82, with a consensus estimate of $7.20.
Broader Healthcare Sector Dynamics
UnitedHealth’s performance cannot be viewed in isolation from broader healthcare sector trends. The company faces ongoing scrutiny over reimbursement rates, medical cost trends, and regulatory developments affecting the insurance industry. Investor concerns about potential changes to healthcare policy have contributed to sector-wide pressure on valuations.
The company remains one of the dominant players in the healthcare insurance space, but investors are closely monitoring how it navigates the evolving competitive landscape and regulatory environment. Comparisons with peer companies in the health insurance subsector provide context for understanding UnitedHealth’s relative valuation.
The healthcare sector has experienced elevated volatility due to policy uncertainty, litigation risks, and earnings variability. Investors should consider the inherent risks when evaluating positions in health insurance stocks during periods of sector-wide stress.
What Do Analysts Say About UNH Stock Outlook?
Analyst perspectives on UnitedHealth present a complex picture, with valuation metrics suggesting significant divergence between current market pricing and fundamental assessments. Understanding these viewpoints requires examining various analytical frameworks and price targets.
Valuation Perspectives
Morningstar’s fair value estimate places UnitedHealth at $914.00 per share, implying the current market price represents approximately 567% of intrinsic value based on this model. This estimate comes with high uncertainty, reflecting the challenges of projecting long-term earnings in a dynamic healthcare environment. Morningstar’s framework includes a 1-star price target of $227.89 and a 5-star price target of $921.90, illustrating the wide range of potential outcomes.
These valuation disparities highlight the ongoing debate about appropriate pricing for healthcare insurance companies. Traditional valuation metrics such as the P/E ratio, which currently ranges from 16.13 to 23.00 depending on the source, suggest the stock may be attractively valued relative to historical averages and peer comparisons.
Price Forecasts and Targets
Forecasting models from Trading Economics suggest continued pressure on UnitedHealth shares. The first quarter 2026 end target stands at $251.25, while the one-year forecast comes in at $229.31. These targets represent meaningful downside from current levels and reflect expectations of persistent headwinds facing the company.
Recent trading has seen the stock oscillate between roughly $271.75 at a 5-week low and $294.33 at a 4-week high, demonstrating the range-bound but pressured nature of recent price action. Some options market activity has been noted as moderately bearish, with light volume of approximately 128,000 contracts suggesting cautious positioning among derivatives traders.
Media and Expert Commentary
UnitedHealth has received mentions in financial media, including appearances on CNBC’s “Halftime Report” alongside other stock picks. However, overall sentiment among options traders and market commentators appears tilted toward caution, with the stock’s significant year-to-date decline drawing attention to potential risks in the healthcare insurance space.
UnitedHealth Share Price Timeline: Key Events
- 52-Week High ($622.83) – UnitedHealth shares reached their highest point within the past year before entering a sustained downtrend.
- Announcement of Medicare Advantage Membership Reduction – The company disclosed plans to drop approximately 1 million members, signaling strategic recalibration.
- Q2 FY2025 Earnings Miss – EPS of $4.08 fell well short of $6.22 consensus estimates, disappointing investors.
- Q3 FY2025 Results – EPS of $2.92 met consensus expectations of $2.90, providing a relative bright spot.
- Q4 FY2025 Performance – EPS of $2.11 to $2.12 exceeded the $2.09 consensus estimate in some data sources.
- 22-Week Low ($294.76) – Stock touched this level in January 2026 amid persistent selling pressure.
- UBS Conference Comments – CFO Wayne DeVey addressed strategy and business outlook at a major healthcare conference.
Confirmed Facts versus Uncertain Information
Confirmed Information
- Current trading range approximately $304-$310 per share
- Market capitalization approximately $276-280 billion
- 52-week range extends from $234.60 to $622.83
- Dividend yield of approximately 2.79-2.8%
- Significant year-over-year decline exceeding 50%
- Plans to reduce Medicare Advantage membership by approximately 1 million
Information Requiring Caution
- Specific earnings consensus estimates vary across data providers
- Price targets represent forecasts with inherent uncertainty
- Duration and sustainability of current downtrend unclear
- Impact of Medicare Advantage changes on long-term profitability not fully established
- Analyst rating distribution and price targets subject to revision
- Specific regulatory developments remain unpredictable
Understanding the Healthcare Insurance Landscape
UnitedHealth Group operates at the intersection of healthcare insurance and services provision, making it one of the most comprehensive players in the American healthcare system. The company’s Optum subsidiary provides healthcare services, creating a vertically integrated model that differs from many pure-play insurance competitors.
For context, investors often compare UnitedHealth with other major health insurers when evaluating relative value. The company’s massive scale, with over 900 million shares outstanding, reflects its position as a cornerstone of the healthcare sector. This scale provides certain advantages in negotiating provider contracts and managing medical costs, but also creates challenges in delivering growth at meaningful multiples.
Broader economic factors, including interest rate expectations, inflation trends, and general market sentiment toward growth versus value stocks, continue to influence how investors price healthcare companies. The recent decline in UnitedHealth shares reflects not only company-specific developments but also the sector’s relative attractiveness compared to other market segments.
Healthcare policy discussions at the federal level continue to affect investor sentiment toward insurance companies. While major structural changes face political obstacles, incremental regulatory adjustments to Medicare Advantage payment rates and coverage requirements can significantly impact profitability expectations.
Sources and Analyst Commentary
Morningstar rates UnitedHealth’s fair value at $914.00, noting high uncertainty in the estimate. The wide gap between fair value estimates and current market pricing reflects divergent views on the company’s earnings trajectory and appropriate sector multiples.
— Morningstar equity analysis
Trading Economics forecasting models suggest continued pressure on UnitedHealth shares, with Q1 2026 targets around $251.25 and one-year forecasts at $229.31. These projections incorporate expectations of persistent headwinds affecting the healthcare insurance sector.
— Trading Economics quantitative models
The company’s investor relations materials, available through UnitedHealth Group’s investor relations website, provide official filings and press releases. Regulatory filings, including annual reports and quarterly submissions, are accessible through the SEC EDGAR database.
Market data platforms including Nasdaq and Yahoo Finance provide ongoing quote updates, historical charts, and analyst coverage information for UnitedHealth shares.
Summary
UnitedHealth Group shares continue to trade under pressure, with the current price near the lower end of the 52-week range at approximately $304-$310 per share. The stock has declined significantly over the past year, losing more than half its value from the $622.83 high. Key factors influencing recent performance include the company’s decision to reduce Medicare Advantage membership, mixed earnings results, and broader concerns about healthcare policy and sector valuations.
Analyst perspectives vary widely, with Morningstar’s fair value estimate suggesting significant upside potential while trading models point toward continued downside. The dividend yield of approximately 2.8% provides some return for shareholders, though capital appreciation prospects remain uncertain. Investors considering positions in UnitedHealth should weigh the company’s dominant market position against the headwinds affecting the healthcare insurance subsector.
For additional information on healthcare providers and related topics, readers may find resources on Bupa Near Me – Find Clinics Dental Health Centres helpful when researching healthcare service options.
Frequently Asked Questions
What is UnitedHealth Group’s current market capitalization?
UnitedHealth Group’s market capitalization stands at approximately $276 to $280 billion, making it one of the largest healthcare companies in the world with over 907 million shares outstanding.
What is the dividend yield for UNH stock?
UnitedHealth Group offers a dividend yield of approximately 2.79% to 2.8%, providing income for shareholders through quarterly distributions.
How has UNH stock performed over the past year?
UnitedHealth shares have declined approximately 50.55% over the past 12 months, falling from levels above $600 to the current range around $304-$310. The stock remains near the lower end of its 52-week range.
What is the 52-week trading range for UnitedHealth?
UnitedHealth shares have traded between a 52-week low of $234.60 and a 52-week high of $622.83, representing significant volatility within the past year.
Why has UnitedHealth stock declined recently?
Multiple factors have contributed to the decline, including the company’s announcement to reduce Medicare Advantage membership by approximately 1 million members, mixed earnings results, and broader concerns about healthcare policy and sector valuations.
What do analysts expect for UnitedHealth stock going forward?
Forecasts vary widely, with some models projecting targets around $229-$251 per share while Morningstar’s fair value estimate stands at $914, suggesting significant divergence in analytical perspectives. All forecasts carry inherent uncertainty.
Where can I find official UnitedHealth investor information?
Official investor relations materials are available through UnitedHealth Group’s investor relations website at unitedhealthgroup.com/investors.html. SEC filings can be accessed through the EDGAR database using the company’s CIK number.
How do I buy UnitedHealth shares?
UnitedHealth Group trades on the New York Stock Exchange under the ticker symbol UNH. Shares can be purchased through any registered brokerage account, with the stock available through major retail and institutional trading platforms.
Related stories
Liam O'Brien covers Australian politics and public affairs for Oz Reviewly.